Navigating the risks: Stakeholder views on risk-based cervical cancer screening
The favorable attitude towards RB CCS among stakeholders provides a strong foundation for advancing its development. However, a comprehensive strategy emphasizing the generation of robust evidence, strengthening healthcare infrastructure, prioritizing patient empowerment, and cultivating a collaborative environment built on trust is crucial.
Authors
- Kadri Suija (ORCID: https://orcid.org/0000-0003-3364-7372)
- Anda Ķīvīte‐Urtāne (ORCID: https://orcid.org/0000-0001-6362-1187)
- L Malina
- Anna Markina
- Gunvor Aasbø (ORCID: https://orcid.org/0000-0002-8981-5374)
- Anneli Uusküla (ORCID: https://orcid.org/0000-0002-4036-3856)
- Mindaugas Stankūnas (ORCID: https://orcid.org/0000-0002-7176-9015)
- Mari Nygård (ORCID: https://orcid.org/0000-0002-4100-4855)
- Anna Tisler (ORCID: https://orcid.org/0000-0002-2055-9421)
- Maali-Liina Remmel (ORCID: https://orcid.org/0009-0001-9449-0105)
Institutions
- Lithuanian University of Health Sciences (LT)
- University of Eastern Finland (FI)
- University of Oslo (NO)
- Riga Stradiņš University (LV)
- Cancer Registry of Norway (NO)
- University of Tartu (EE)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-03-05
- DOI
- https://doi.org/10.1371/journal.pone.0317986
- Citations
- 1
- Primary Topic
- Global Cancer Incidence and Screening
- Type
- article
- Field-Weighted Citation Impact
- 1.05
Funders
- EEA Grants/Norway Grants